EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hepsin promotes breast tumor growth signaling via the TGFβ‐EGFR axis

Denis Belitškin iD, Pauliina Munne, Shishir M Pant, Johanna M Anttila, Ilida Suleymanova, Kati Belitškina iD, Daniel Kirchhofer, James Janetka, Taivo Käsper, Sami Jalil, Jeroen Pouwels, Topi A Tervonen und 1 weitere

Molecular Oncology · 2024

DOI: 10.1002/1878-0261.13545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2024. Verfasst von Denis Belitškin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, University of Helsinki, Finland. Hauptthemen laut MEDLINE: Breast Neoplasms, Epidermal Growth Factor, Serine Endopeptidases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepsin, a type II transmembrane serine protease, is commonly overexpressed in prostate and breast cancer. The hepsin protein is stabilized by the Ras‐MAPK pathway, and, downstream, this protease regulates the degradation of extracellular matrix components and activates growth factor pathways, such as the hepatocyte growth factor (HGF) and transforming growth factor beta (TGFβ) pathway. However, how exactly active hepsin promotes cell proliferation machinery to sustain tumor growth is not fully understood. Here, we show that genetic deletion of the gene encoding hepsin ( Hpn ) in a WAP‐Myc model of aggressive MYC‐driven breast cancer inhibits tumor growth in the primary syngrafted sites and the growth of disseminated tumors in the lungs. The suppression of tumor growth upon loss of hepsin was accompanied by downregulation of TGFβ and EGFR signaling together with a reduction in epidermal growth factor receptor (EGFR) protein levels. We further demonstrate in 3D cultures of patient‐derived breast cancer explants that both basal TGFβ signaling and EGFR protein expression are inhibited by neutralizing antibodies or small‐molecule inhibitors of hepsin. The study demonstrates a role for hepsin as a regulator of cell proliferation and tumor growth through TGFβ and EGFR pathways, warranting consideration of hepsin as a potential indirect upstream target for therapeutic inhibition of TGFβ and EGFR pathways in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsEpidermal Growth FactorSerine EndopeptidasesHumansMaleCell Line, TumorErbB ReceptorsReceptors, Transforming Growth Factor betaTransforming Growth Factor beta

Stichwörter der Autor:innen

HPNEGFRTGFβbreast cancermouse cancer modelpatient-derived explant culture model

Substanzen

EGFR protein, humanEpidermal Growth FactorErbB ReceptorshepsinReceptors, Transforming Growth Factor betaSerine EndopeptidasesTransforming Growth Factor betaHPN protein, human

Autor:innen und Institutionen

  • Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, University of Helsinki, Finland.
  • Pathology Department, North Estonia Medical Centre, Tallinn, Estonia.
  • Department of Early Discovery Biochemistry, Genentech, Inc., South San Francisco, CA, USA.
  • Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, USA.
  • Sixfold OÜ, Tartu, Estonia.
  • Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Finland.

ORCID-Profile: Denis Belitškin, Kati Belitškina, Juha Klefström

Zitieren

APA

Belitškin, D., Munne, P., Pant, S. M., Anttila, J. M., Suleymanova, I., Belitškina, K., Kirchhofer, D., Janetka, J., Käsper, T., Jalil, S., Pouwels, J., Tervonen, T. A., & Klefström, J. (2024). Hepsin promotes breast tumor growth signaling via the TGFβ‐EGFR axis. Molecular Oncology. https://doi.org/10.1002/1878-0261.13545

Vancouver

Belitškin D, Munne P, Pant SM, Anttila JM, Suleymanova I, Belitškina K, et al. Hepsin promotes breast tumor growth signaling via the TGFβ‐EGFR axis. Molecular Oncology. 2024. doi:10.1002/1878-0261.13545

BibTeX
@article{Belitkin2024,
  author = {Belitškin, Denis and Munne, Pauliina and Pant, Shishir M and Anttila, Johanna M and Suleymanova, Ilida and Belitškina, Kati and Kirchhofer, Daniel and Janetka, James and Käsper, Taivo and Jalil, Sami and Pouwels, Jeroen and Tervonen, Topi A and Klefström, Juha},
  title = {Hepsin promotes breast tumor growth signaling via the TGFβ‐EGFR axis},
  journal = {Molecular Oncology},
  year = {2024},
  doi = {10.1002/1878-0261.13545}
}
Kostenlos starten →